版本:
中国

BRIEF-Voyager Therapeutics selects lead clinical candidate for Huntington's Disease

June 1 Voyager Therapeutics Inc:

* Voyager Therapeutics selects lead clinical candidate for Huntington's Disease

* Voyager Therapeutics -preclinical pharmacology and toxicology studies are now underway with VY-htt01 to support filing of an IND application in 2018

* Voyager Therapeutics Inc says selection of VY-htt01, a clinical candidate for treatment of Huntington's Disease Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐